DAFNA CAPITAL MANAGEMENT LLC – Lineage Cell Therapeutics, Inc. Transaction History
DAFNA CAPITAL MANAGEMENT LLC portfolio value:
$158,000
portfolio value
DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:
-28.48%
quarter
Lineage Cell Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -63K | $1.13 | 140K | |
| Q2 2022 | share | 0.00% | 0 shares | 5K | $1.58 | 140K | |
| Q1 2022 | share | Increase | +75.00% | 60K shares | 20K | $1.54 | 140K |
| Q4 2021 | share | Increase | 0.00% | 80K shares | 196K | $2.5 | 80K |
| Q2 2021 | share | Decrease | -100.00% | -75.4K shares | -177K | $2.85 | 0 |
| Q1 2021 | share | Decrease | -5.75% | -4.6K shares | 36K | $2.35 | 75.4K |
| Q4 2020 | share | Decrease | -15.79% | -15K shares | 52K | $1.76 | 80K |
| Q3 2020 | share | 0.00% | 0 shares | 6K | $0.94 | 95K | |
| Q2 2020 | share | 0.00% | 0 shares | 4K | $0.87 | 95K | |
| Q1 2020 | share | 0.00% | 0 shares | -6K | $0.83 | 95K | |
| Q4 2019 | share | 0.00% | 0 shares | -8K | $0.89 | 95K | |
| Q3 2019 | share | Increase | 0.00% | 95K shares | 93K | $0.98 | 95K |